J&J says it has settled some talc claims, will continue bankruptcy
strategy
Send a link to a friend
[December 06, 2023]
By Brendan Pierson
(Reuters) - Johnson & Johnson's worldwide vice president for litigation
said on Tuesday that the company has recently reached settlements with
several law firms over their clients' claims that J&J talc products
caused cancer.
The settlements were reached "with a goal to facilitate our pursuit of a
consensual prepackaged bankruptcy resolution," Erik Haas said on an
investor call. It was not clear whether the deals have been finalized.
J&J said in October that it was considering a new bankruptcy filing to
resolve talc claims. Courts have rejected its two previous attempts to
resolve talc litigation through bankruptcy, most recently a proposed
$8.9 billion deal.
Haas said the recent settlements covered cases involving plaintiffs with
mesothelioma, a type of cancer linked to asbestos, but did not provide
any details about the dollar amounts involved or say how many people
they covered.
He said the company had resolved all but one of the cases scheduled for
trial in 2023, "significantly curtailed" trials in 2024 and did not
require the company to record any new charges against earnings.
Bloomberg reported earlier on Tuesday that J&J had reached settlements
covering about 100 people.
J&J faces more than 50,000 lawsuits over talc, most by women with
ovarian cancer, with a minority of the cases involving people with
mesothelioma. The company has said that its talc products are safe and
do not contain asbestos.
[to top of second column]
|
A bottle of Johnson and Johnson's baby powder is seen in a photo
illustration taken in New York, February 24, 2016. REUTERS/Mike
Segar/Illustration/File Photo
The lawsuits, which had mostly been
on hold for about two years while J&J petitioned the bankruptcy
court, have now been able to resume.
Trials in the talc cases have had a mixed record, with major
plaintiff wins including a $2.1 billion judgment in 2021 awarded to
22 women with ovarian cancer. A New Jersey appeals court in October
threw out a $223.7 million verdict against the company, finding the
testimony of the plaintiffs' expert witnesses unsound.
The company stopped selling talc-based baby powder in favor of
cornstarch-based products, citing an increase in lawsuits and
"misinformation" about the talc product's safety.
(Reporting By Brendan Pierson in New York, Editing by Alexia
Garamfalvi and Bill Berkrot)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |